Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medtronic Inc (MDT)

Medtronic Inc (MDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 159,853,360
  • Shares Outstanding, K 1,340,377
  • Annual Sales, $ 30,557 M
  • Annual Income, $ 4,631 M
  • 60-Month Beta 0.60
  • Price/Sales 5.31
  • Price/Cash Flow 16.64
  • Price/Book 3.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 01/31/20
See More
  • Average Estimate 1.38
  • Number of Estimates 13
  • High Estimate 1.39
  • Low Estimate 1.38
  • Prior Year 1.29
  • Growth Rate Est. (year over year) +6.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
112.15 +6.34%
on 12/26/19
122.15 -2.36%
on 01/22/20
+5.49 (+4.83%)
since 12/24/19
3-Month
104.64 +13.97%
on 10/25/19
122.15 -2.36%
on 01/22/20
+13.97 (+13.27%)
since 10/24/19
52-Week
82.77 +44.09%
on 04/18/19
122.15 -2.36%
on 01/22/20
+32.03 (+36.72%)
since 01/24/19

Most Recent Stories

More News
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know

Medtronic (MDT) closed the most recent trading day at $120.97, moving -0.1% from the previous trading session.

MDT : 119.26 (-1.41%)
New Product Suite Boosts Intersect ENT Despite Cost Concerns

With respect to Intersect ENT's (XENT) Propel line, the PROPEL suite scores as the standard of care for polyp patients undergoing sinus surgery.

XENT : 24.79 (-0.96%)
MDT : 119.26 (-1.41%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
Medtronic Receives FDA Approval for Trial Evaluating New Energy Source with Pulsed Electric Fields to Treat Atrial Fibrillation

Investigative Technology Designed to Interrupt Irregular Pathways in the Heart

MDT : 119.26 (-1.41%)
Medtronic Launches Efficio(TM) Software to Help Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed(TM) II

Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers

MDT : 119.26 (-1.41%)
Zimmer Biomet Rides on Product Launches Despite Pricing Woes

Zimmer Biomet's (ZBH) execution of its priority agenda including quality remediation, supply recovery efforts and product introductions looks impressive.

HAE : 107.45 (-2.37%)
HRC : 109.64 (-2.81%)
MDT : 119.26 (-1.41%)
ZBH : 147.80 (-1.14%)
Medtronic (MDT) Gets FDA Nod for Micra AV to Treat AV Block

Medtronic's (MDT) Micra AV cleared by the FDA for the treatment of AV block in patients eligible for pacemaker implantation.

MDT : 119.26 (-1.41%)
HRC : 109.64 (-2.81%)
HAE : 107.45 (-2.37%)
MYO : 0.32 (-3.03%)
Gastro Esophageal Reflux Disease Drug and Devices Market 2019 Global Overview, Latest Technologies, Business Strategy, Key Vendors, Segments, Demands, Growth Factors, Size, Share by Forecast to 2025

A recent report provides crucial insights along with application based and forecast information in the Global Gastro Esophageal Reflux Disease Drug and Devices Market. The report provides a comprehensive...

AZN : 49.28 (-1.83%)
BSX : 43.21 (-0.83%)
CEMP : 2.33 (+1.30%)
STIM : 4.19 (-1.87%)
GSK : 47.23 (-1.23%)
IRWD : 12.37 (-3.59%)
MDGS : 1.87 (unch)
MDT : 119.26 (-1.41%)
MRK : 85.98 (-2.91%)
NVS : 93.87 (-1.11%)
PFE : 39.82 (-2.19%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
DTM(TM) Spinal Cord Stimulation Using the Medtronic Intellis(TM) Platform Shows Superior Back Pain Relief Compared to Conventional SCS Therapy in an RCT

At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Relief

MDT : 119.26 (-1.41%)
FDA Approves Medtronic Micra(TM) AV, the World's Smallest Pacemaker Which Can Now Treat AV Block

With FDA Approval, More Patients in the U.S. Are Now Candidates for a Leadless Pacing Option

MDT : 119.26 (-1.41%)
Medtronic Named to FORTUNE's 2020 World's Most Admired Companies List

Global Leader in Medical Technology Ranks #2 in Industry on Annual List

MDT : 119.26 (-1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MDT with:

Business Summary

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders...

See More

Key Turning Points

2nd Resistance Point 121.88
1st Resistance Point 120.57
Last Price 119.26
1st Support Level 118.41
2nd Support Level 117.55

See More

52-Week High 122.15
Last Price 119.26
Fibonacci 61.8% 107.11
Fibonacci 50% 102.46
Fibonacci 38.2% 97.81
52-Week Low 82.77

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar